Linear–Dendritic Copolymer Composed of Polyethylene Glycol and All-trans-Retinoic Acid as Drug Delivery Platform for Paclitaxel against Breast Cancer
- 12 February 2015
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 26 (3) , 418-426
Abstract
A new linear–dendritic copolymer composed of poly(ethylene glycol) (PEG) and all-trans-retinoic acid (ATRA) was synthesized as the anticancer drug delivery platform (PEG-G3-RA8). It can self-assemble into core–shell micelles with a low critical micelle concentration (CMC) at 3.48 mg/L. Paclitaxel (PTX) was encapsulated into PEG-G3-RA8 to form PEG-G3-RA8/PTX micelles for breast cancer treatment. The optimized formulation had high drug loading efficacy (20% w/w of drug copolymer ratio), nanosized diameter (27.6 nm), and narrow distribution (PDI = 0.103). Compared with Taxol, PEG-G3-RA8/PTX remained highly stable in the serum-containing cell medium and exhibited 4-fold higher cellular uptake. Besides, near-infrared fluorescence (NIR) optical imaging results indicated that fluorescent probe loaded micelle had a preferential accumulation in breast tumors. Pharmacokinetics and biodistribution studies (10 mg/kg) showed the area under the plasma concentration–time curve (AUC0-∞) and mean residence time (MRT0-∞) for PEG-G3-RA8/PTX and Taxol were 12.006 ± 0.605 mg/L h, 2.264 ± 0.041 h and 15.966 ± 1.614 mg/L h, 1.726 ± 0.097 h, respectively. The tumor accumulation of PEG-G3-RA8/PTX group was 1.89-fold higher than that of Taxol group 24 h postinjection. With the advantages like efficient cellular uptake and preferential tumor accumulation, PEG-G3-RA8/PTX showed superior therapeutic efficacy on MCF-7 tumor bearing mice compared to Taxol.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2013CB932500)
- National Natural Science Foundation of China (81172993, 81425023)
This publication has 42 references indexed in Scilit:
- Environmental pH-sensitive polymeric micelles for cancer diagnosis and targeted therapyJournal of Controlled Release, 2013
- A novel delivery system of doxorubicin with high load and pH-responsive release from the nanoparticles of poly (α,β-aspartic acid) derivativeEuropean Journal of Pharmaceutical Sciences, 2012
- Pharmacokinetics of a paclitaxel-loaded low molecular weight heparin-all-trans-retinoid acid conjugate ternary nanoparticulate drug delivery systemBiomaterials, 2012
- PEG-Derivatized Embelin as a Dual Functional Carrier for the Delivery of PaclitaxelBioconjugate Chemistry, 2012
- Stability Influences the Biodistribution, Toxicity, and Anti-tumor Activity of Doxorubicin Encapsulated in PEG-PE Micelles in MicePharmaceutical Research, 2012
- A self-assembling nanoparticle for paclitaxel delivery in ovarian cancerBiomaterials, 2009
- Effect of Tail Architecture on Self-Assembly of Amphiphiles for Polymeric MicellesLangmuir, 2009
- Nanoparticle therapeutics: an emerging treatment modality for cancerNature Reviews Drug Discovery, 2008
- Computer Simulation of Architectural and Molecular Weight Effects on the Assembly of Amphiphilic Linear−Dendritic Block Copolymers in SolutionLangmuir, 2008
- Preparation and characterization of size-controlled polymeric micelle containing cis-dichlorodiammineplatinum(II) in the coreJournal of Controlled Release, 2001